Eligibility DRKS00003883 NCT00626548 Prostate Cancer

A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer (ENTHUSE M0) see http://clinicaltrials.gov/ct2/show/study/NCT00626548

Eligibility NCT00626548

  1. StudyEvent: Eligibility
    1. Eligibility NCT00626548
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI-1)
Age
Item
18 Years and older
boolean
C0001779 (UMLS CUI-1)
Gender Male
Item
Male
boolean
C0086582 (UMLS CUI-1)
Prostate Cancer
Item
Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has NOT spread to the other parts of the body (metastases). Patients with lymph node involvement may be eligible if specified criteria is met.
boolean
C0600139 (UMLS CUI-1)
PSA
Item
Increasing Prostate Specific Antigen (PSA), collected within one year of enrollment
boolean
C0138741 (UMLS CUI-1)
Castration
Item
Currently receiving treatment with surgical or medical castration
boolean
C0007347 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI-1)
Opiate
Item
Currently using opiate based pain killers for cancer related pain
boolean
C0376196 (UMLS CUI-1)
Previous chemotherapy
Item
Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone). Prior targeted cancer therapies are permitted if received during a previous clinical trial
boolean
C1514457 (UMLS CUI-1)
Heart disease
Item
Suffering from heart failure or had a myocardial infarction within last 6 months
boolean
C0018799 (UMLS CUI-1)
Epilepsy
Item
A history of epilepsy or seizures
boolean
C0014544 (UMLS CUI-1)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial